durvalumab 500 MG per 10 ML Injection

RxCUI: 1919515
RxNorm name: durvalumab 500 MG per 10 ML Injection
Display name: durvalumab 500 MG per 10 ML Injection
Full name: durvalumab 500 MG per 10 ML Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:07

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761069	Imfinzi	durvalumab	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
IMFINZI	DURVALUMAB	AstraZeneca Pharmaceuticals LP	8baba4ea-2855-42fa-9bd9-5a7548d4cec3	2026-05-28	Warnings, Adverse reactions	Exact identifier rxcui: 1919515

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
8baba4ea-2855-42fa-9bd9-5a7548d4cec3	durvalumab 500 MG per 10 ML Injection	SY	32	These highlights do not include all the information needed to use IMFINZI safely and effectively. See full prescribing information for IMFINZI. IMFINZI ® (durvalumab) injection, for intravenous use Initial U.S. Approval: 2017	20251125
8baba4ea-2855-42fa-9bd9-5a7548d4cec3	durvalumab 500 MG in 10 ML Injection	PSN	32	These highlights do not include all the information needed to use IMFINZI safely and effectively. See full prescribing information for IMFINZI. IMFINZI ® (durvalumab) injection, for intravenous use Initial U.S. Approval: 2017	20251125
8baba4ea-2855-42fa-9bd9-5a7548d4cec3	10 ML durvalumab 50 MG/ML Injection	SCD	32	These highlights do not include all the information needed to use IMFINZI safely and effectively. See full prescribing information for IMFINZI. IMFINZI ® (durvalumab) injection, for intravenous use Initial U.S. Approval: 2017	20251125